This has been linked to lifestyle changes, metabolic diseases, and obesity, with cases increasingly being reported in women ...

Part of that spike is due to rising rates of cancers that affect primarily women, including breast cancer and endometrial ...

The addition of radiation to chemotherapy did not improve overall survival in patients with locally advanced endometrial ...

Merck and Eisai said on Friday a combination of their cancer therapies failed to extend the lives of patients with a type of ...

Jemperli (dostarlimab) in combination with chemotherapy (carboplatin and paclitaxel) for first-line treatment of adult ...

Uterine manipulation with an intrauterine device is the surgical method used for early-stage cervical cancer. In this study, ...

GSK’s Jemperli is designed to help the body’s immune system find and attack cancer cells, and is already approved in the EU ...

GSK (GSK) announced the European Commission has approved Jemperli, or dostarlimab, in combination with chemotherapy for first-line treatment of ...

Meanwhile, J&J has claimed EU approval for its combination of EGFRxMET bispecific antibody Rybrevant (amivantamab) with third ...

Incidences for many common types of cancer have risen in recent years, with young women experiencing the brunt of the shift.

The American Cancer Society's annual cancer trend report shows cancer mortality is decreasing but cancer rates are increasing in young adults and women.